Status:

WITHDRAWN

Safety Assessment of Iron Sucrose (Venofer) in Patients With Chronic Kidney Disease Who Cannot Tolerate Ferumoxytol (Feraheme) or Iron Dextran (INFed or Dexferrum)

Lead Sponsor:

American Regent, Inc.

Conditions:

Iron Deficiency Anemia

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The objective of this study is to assess the safety and tolerability of Venofer in patients with chronic kidney disease who cannot tolerate Ferumoxytol (Feraheme) or intravenous iron containing a dext...

Detailed Description

This is a Phase IV, multi-center, open label study that assesses the safety and tolerability of Iron Sucrose (Venofer) in subjects with CKD who require intravenous iron for the treatment of iron defic...

Eligibility Criteria

Inclusion

  • Male or female subjects \> or = to 18 years of age
  • Determined by treating physician to have chronic kidney disease and require a course of intravenous iron
  • Subject did not tolerate an intravenous iron containing a dextran or Ferumoxytol within the last year
  • Subjects with hemodialysis-dependent or peritoneal dialysis chronic kidney disease should be receiving an erythropoiesis stimulating agent (ESA) as per the iron sucrose package insert

Exclusion

  • Known history of hypersensitivity or significant intolerance to iron sucrose
  • Evidence of iron overload
  • Hemochromatosis or other iron storage disorders
  • Received an investigational drug within 30 days of screening
  • Any other laboratory abnormality, medical condition or psychiatric disorder which would put the subject's disease management at risk or may result in the subject being unable to comply with study requirements
  • Pregnant or sexually-active female subjects who are of childbearing potential and who are not willing to use an acceptable form of contraception

Key Trial Info

Start Date :

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT01151592

Last Update

January 24 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Luitpold Pharmaceuticals, Inc.

Norristown, Pennsylvania, United States, 19403